Study to Examine the Effects of MultiStem in Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

Also called NCT01436487

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
  • Healios K.K. Registry lists this organization as the lead sponsor
  • Medpace, Inc. Registry lists this organization as a collaborator
Registry
  • NCT NCT01436487
Other papers using this trial's data
  • Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial The Lancet. Neurology, 2017-05 DOI, PubMed 28320635

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01436487. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2015-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Examine the Effects of MultiStem in Ischemic Stroke
Intervention (Biological)
MultiStem
Intervention (Biological)
Placebo
Lead sponsor
Healios K.K. (class: industry)
Collaborator
Medpace, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01436487
Content hash
7063f8d04b441daa8d46c42eca409eea6bc27e92eaf78a26d7f80742e32f1c62